Cellectar Biosciences, Inc. — Director's Dealing 2023

Jun 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2023-06-28

Reporting Person: Loren Stefan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-28	Stock option (right to buy)	$1.85	A	25000	Acquired	2033-06-28	Common Stock (25000)	Direct

Footnotes

F1: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date.